CA2549969A1 - Alkynes ii - Google Patents
Alkynes ii Download PDFInfo
- Publication number
- CA2549969A1 CA2549969A1 CA002549969A CA2549969A CA2549969A1 CA 2549969 A1 CA2549969 A1 CA 2549969A1 CA 002549969 A CA002549969 A CA 002549969A CA 2549969 A CA2549969 A CA 2549969A CA 2549969 A1 CA2549969 A1 CA 2549969A1
- Authority
- CA
- Canada
- Prior art keywords
- hydrogen
- alkyl
- prop
- thio
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/14—Preparation from compounds containing heterocyclic oxygen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56071403P | 2003-10-31 | 2003-10-31 | |
US56071303P | 2003-10-31 | 2003-10-31 | |
US60/560,713 | 2003-10-31 | ||
US60/560,714 | 2003-10-31 | ||
PCT/US2004/034519 WO2005044267A1 (en) | 2003-10-31 | 2004-10-20 | Alkynes ii |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2549969A1 true CA2549969A1 (en) | 2005-05-19 |
Family
ID=34577141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002549969A Abandoned CA2549969A1 (en) | 2003-10-31 | 2004-10-20 | Alkynes ii |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1677790A1 (de) |
JP (1) | JP2007509935A (de) |
CA (1) | CA2549969A1 (de) |
WO (1) | WO2005044267A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0413605D0 (en) * | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
CA2663113A1 (en) | 2006-09-11 | 2008-03-20 | Novartis Ag | Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
CN102131503A (zh) | 2008-06-30 | 2011-07-20 | 诺瓦提斯公司 | 用于治疗帕金森病的包含mGluR调节剂的组合产品 |
EP2959902A1 (de) | 2009-07-23 | 2015-12-30 | Novartis AG | Verwendung von azabicycloalkylderivaten zur behandlung oder vorbeugung von ataxie |
TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α7活化劑之用途 |
WO2011048150A1 (en) | 2009-10-20 | 2011-04-28 | Novartis Ag | Use of 1h-quinazoline-2,4-diones |
CA2800970A1 (en) | 2010-06-24 | 2011-12-29 | Novartis Ag | Use of 1h-quinazoline-2,4-diones |
CA2825142A1 (en) | 2011-01-27 | 2012-08-02 | Novartis Ag | Use of nicotinic acetylcholine receptor alpha 7 activators |
CN103889427A (zh) | 2011-09-07 | 2014-06-25 | 诺华股份有限公司 | 1h-喹唑啉-2,4-二酮用于预防或治疗光敏性癫痫的应用 |
WO2014111751A1 (en) | 2013-01-15 | 2014-07-24 | Novartis Ag | Use of alpha 7 nicotinic receptor agonists for the treatment of narcolepsy |
JP2016508159A (ja) | 2013-01-15 | 2016-03-17 | ノバルティス アーゲー | アルファ7ニコチン性アセチルコリン受容体アゴニストの使用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
WO2001016121A1 (en) * | 1999-08-31 | 2001-03-08 | Merck & Co., Inc. | Heterocyclic compounds and methods of use thereof |
US6800651B2 (en) * | 2000-02-03 | 2004-10-05 | Eli Lilly And Company | Potentiators of glutamate receptors |
GB0103045D0 (en) * | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
-
2004
- 2004-10-20 JP JP2006538085A patent/JP2007509935A/ja active Pending
- 2004-10-20 CA CA002549969A patent/CA2549969A1/en not_active Abandoned
- 2004-10-20 WO PCT/US2004/034519 patent/WO2005044267A1/en not_active Application Discontinuation
- 2004-10-20 EP EP04795655A patent/EP1677790A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1677790A1 (de) | 2006-07-12 |
JP2007509935A (ja) | 2007-04-19 |
WO2005044267A1 (en) | 2005-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6869947B2 (ja) | 置換キナゾリン化合物ならびにそのg12c変異kras、hrasおよび/またはnrasタンパク質の阻害剤としての使用 | |
TWI453197B (zh) | 可用作抗菌劑之氟吡啶酮衍生物 | |
AU637617B2 (en) | 1-((biphenyl-4-yl)alkyl)-6-oxopyrimidine derivatives | |
US20210387941A1 (en) | Diphenyl-like Compound, Intermediate Thereof, Preparation Method Therefor, Pharmaceutical Composition Thereof And Uses Thereof | |
JP5315254B2 (ja) | 溶媒和物化されたイラプラゾールの結晶形 | |
US20080125427A1 (en) | Novel Inhibitors of Rho-Kinases | |
CS196290B2 (en) | Process for preparing new compounds | |
JP2010501003A (ja) | ピラジン化合物、その使用及び調製方法 | |
CA2549967A1 (en) | Alkynes i | |
CA2549969A1 (en) | Alkynes ii | |
TWI613182B (zh) | 雙環化合物 | |
EP2107054A1 (de) | Antiproliferative Verbindungen und therapeutische Verwendungen dafür | |
KR20230012597A (ko) | Ampk 활성화제 | |
CA2549965A1 (en) | Alkynes iii | |
EA027882B1 (ru) | Этинильные производные в качестве антагонистов метаботропного глутаматного рецептора | |
LU86248A1 (fr) | Derives a cycle imidique de 2-(4-butylpiperazine-1-yl)pyridines et leur application antipsychotique | |
RU2345074C2 (ru) | Производные имидазола, способ их получения и их применение, лекарственное средство | |
WO2005082884A2 (en) | 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease | |
JP4571631B2 (ja) | イミダゾール誘導体iii | |
US20050222228A1 (en) | Novel diazine derivatives | |
JP2008500299A (ja) | 2−スチリル−4−オキサゾール−メタノール−エーテル及びチロシンキナーゼ阻害剤としてのその使用 | |
JP2004509870A (ja) | ヒスタミンh1およびヒスタミンh3双方のアゴニストまたはアンタゴニストとしての置換イミダゾール | |
WO2022067063A1 (en) | Mutant selective egfr inhibitors and methods of use thereof | |
WO2022037601A1 (zh) | 作为ep4受体拮抗剂的吡唑酰胺衍生物及其在制备治疗癌症和炎症药物中的用途 | |
AU2020221291A1 (en) | Isotopically-stabilized tetronimide compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |